SANTINI, DAVIDE
 Distribuzione geografica
Continente #
AS - Asia 2.825
NA - Nord America 1.885
EU - Europa 1.115
AF - Africa 135
SA - Sud America 124
Continente sconosciuto - Info sul continente non disponibili 105
OC - Oceania 2
Totale 6.191
Nazione #
US - Stati Uniti d'America 1.838
VN - Vietnam 1.119
SG - Singapore 600
CN - Cina 516
IT - Italia 322
HK - Hong Kong 202
SE - Svezia 141
DE - Germania 129
GB - Regno Unito 98
KR - Corea 86
BR - Brasile 83
FR - Francia 77
IN - India 66
BD - Bangladesh 65
FI - Finlandia 64
IE - Irlanda 53
NL - Olanda 53
CI - Costa d'Avorio 49
CH - Svizzera 46
JP - Giappone 29
RU - Federazione Russa 28
AT - Austria 26
SC - Seychelles 26
CA - Canada 23
TG - Togo 22
JO - Giordania 21
PH - Filippine 21
BG - Bulgaria 19
PL - Polonia 19
AR - Argentina 17
ID - Indonesia 16
NG - Nigeria 13
TH - Thailandia 13
PK - Pakistan 11
TW - Taiwan 11
ZA - Sudafrica 10
MX - Messico 9
TR - Turchia 9
CO - Colombia 8
IQ - Iraq 8
SA - Arabia Saudita 8
UA - Ucraina 8
BE - Belgio 7
ES - Italia 7
EC - Ecuador 5
JM - Giamaica 5
UZ - Uzbekistan 5
VE - Venezuela 5
LT - Lituania 4
OM - Oman 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
NI - Nicaragua 3
PT - Portogallo 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
LB - Libano 2
ML - Mali 2
MU - Mauritius 2
NP - Nepal 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
MA - Marocco 1
MK - Macedonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.087
Città #
Singapore 399
Ho Chi Minh City 312
Ashburn 256
Hanoi 249
Hong Kong 183
San Jose 177
Hefei 146
Chandler 133
Santa Clara 103
Bologna 93
Fairfield 79
Seoul 74
Los Angeles 69
Beijing 67
Southend 66
Dallas 62
Da Nang 55
Dublin 53
Boardman 52
Abidjan 49
New York 49
Bern 46
Helsinki 46
Seattle 43
Haiphong 41
Houston 39
Council Bluffs 38
Woodbridge 35
Princeton 33
Lauterbourg 29
Cambridge 28
Munich 27
Tokyo 24
Turin 24
Wilmington 23
Lomé 22
Amman 21
Buffalo 21
Bến Tre 20
Biên Hòa 19
Sofia 19
Milan 18
Redondo Beach 17
Vienna 17
Thái Nguyên 16
Florence 15
Frankfurt am Main 15
Berlin 14
Can Tho 14
Bengaluru 13
Phoenix 13
Shanghai 13
São Paulo 13
Abeokuta 12
Chicago 12
Falkenstein 12
Guangzhou 12
Orem 12
Redmond 12
Warsaw 12
Hải Dương 11
Quận Bình Thạnh 11
Bắc Ninh 10
Lappeenranta 10
Amsterdam 9
Jakarta 9
London 9
Shenzhen 9
Vũng Tàu 9
Westminster 9
Ann Arbor 8
Bắc Giang 8
Montreal 8
Nha Trang 8
Ninh Bình 8
Nuremberg 8
Rimini 8
The Dalles 8
Thái Bình 8
Bremen 7
Brussels 7
Charlotte 7
Quận Một 7
Rome 7
Toronto 7
Turku 7
Tân Tiến 7
Washington 7
Des Moines 6
Huế 6
Hyderabad 6
Mexico City 6
Stockholm 6
Boston 5
Cao Lanh 5
Changsha 5
Chengdu 5
Denver 5
Genoa 5
Ha Long 5
Totale 3.882
Nome #
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 336
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 248
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 240
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 229
HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles 224
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer 216
Bone metastases in biliary cancers: A multicenter retrospective survey 203
Relevance of ARID1A Mutations in Endometrial Carcinomas 200
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 187
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 185
Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. 182
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 177
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib 173
Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients 171
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 168
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline ☆ 167
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 165
Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity 163
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 162
The Italian Rare Pancreatic Exocrine Cancer Initiative 160
An exceptional case of primary ovarian angiosarcoma 159
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice—a fifteen-year journey at a tertiary referral centre 158
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 129
What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study 123
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 121
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult 114
CAR-T cell therapy: A potential new strategy against prostate cancer 105
A clinically applicable integrated molecular, immunohistochemical and histological approach for endometrial carcinoma. 104
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives 101
Integrated histopathologic and molecular classification of endometri- al carcinoma: identification of prognostic subgroups 100
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 100
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy 91
Ovarian mixed malignant Brenner-mucinous tumour: report of a unique case 85
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study 84
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 80
PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA: CLINICOPATHOLOGIC AND GENETIC FEATURES 77
Risk stratification for pheochromocytoma and paraganglioma: a comparison of pathological scores for prediction of metastatic potential. 77
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization 72
Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts 71
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 62
Pathological and immunohistochemical features of ovarian neuroendocrine tumor: a single center experience. 61
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 39
Erratum: Microscopic margins of resection influence primary gastrointestinal stromal tumor survival (Onkologie (2012) 35 (645-648)) 38
Pathologic findings in risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA1 or BRCA2 mutations: a single center experience. 37
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 29
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors 18
Totale 6.191
Categoria #
all - tutte 19.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022314 0 9 17 27 30 12 4 14 30 38 95 38
2022/2023669 36 62 28 63 75 66 21 41 143 23 41 70
2023/2024236 28 41 20 21 9 49 7 9 10 14 10 18
2024/20251.058 54 131 72 69 145 56 47 60 20 77 86 241
2025/20263.385 492 259 247 200 252 103 689 112 551 226 124 130
2026/202799 64 35 0 0 0 0 0 0 0 0 0 0
Totale 6.191